BPAN, or beta-propeller protein-associated neurodegeneration, is a rare genetic condition that causes iron to build up in the brain, leading to developmental delays in childhood and progressive movement and cognitive problems in adulthood. It affects an estimated 2 to 3 people per million and is the most common form of a group of disorders called neurodegeneration with brain iron accumulation (NBIA), accounting for 35 to 45 percent of all NBIA cases.
What Causes BPAN
BPAN is caused by a mutation in a gene called WDR45, located on the X chromosome. This gene plays an important role in autophagy, the process your cells use to clean up damaged components and recycle them. The WDR45 protein helps build and mature the tiny structures (called autophagosomes) that engulf cellular waste. When this protein doesn’t work properly, cells can’t clean house effectively, which leads to problems with energy-producing structures in cells, stress in the cell’s internal packaging system, and most notably, a buildup of iron in a deep brain region called the basal ganglia.
The connection between faulty cleanup and iron buildup appears to involve a specific recycling process for ferritin, the protein that stores iron. When cells can’t properly break down and recycle ferritin, iron accumulates where it shouldn’t. In lab studies using brain cells derived from BPAN patients, boosting the autophagy process reduced iron overload and restored ferritin to more normal levels, which suggests the iron buildup is a direct consequence of the cleanup failure rather than a separate problem.
In most cases, the WDR45 mutation occurs spontaneously and is not inherited from either parent. Rarely, an unaffected parent who carries the mutation in only some of their cells (a situation called mosaicism) can pass it on. Because WDR45 sits on the X chromosome, BPAN affects both males and females, though the clinical picture can differ between them.
Childhood Symptoms
BPAN typically becomes apparent in infancy or early childhood. The earliest signs are global developmental delay and intellectual disability. Children have significant difficulty with speech, particularly producing words and building vocabulary. Coordination problems (ataxia) are also common, making movement clumsy or unsteady.
Seizures are one of the hallmark childhood features. They often begin as febrile seizures, triggered by high fever. Over time, children may experience several different seizure types, sometimes even within the same individual. These can include generalized tonic-clonic seizures (full-body convulsions), absence seizures that look like staring spells or daydreaming, sudden episodes of muscle weakness (atonic seizures), brief involuntary twitches (myoclonic seizures), or more pronounced movements called epileptic spasms. Some children develop seizure patterns resembling recognized epileptic syndromes such as West syndrome or Lennox-Gastaut syndrome.
Many children with BPAN also show features that closely resemble Rett syndrome: repetitive hand wringing or clasping, teeth grinding, sleep disturbances, and difficulties with communication and social interaction that overlap with autism spectrum disorder. These Rett-like features can sometimes lead to an initial misdiagnosis before genetic testing confirms BPAN.
The Adult Phase: Movement and Cognitive Decline
BPAN follows a distinctive two-phase pattern. After a relatively stable (though delayed) childhood, a second phase of neurological deterioration begins in adolescence or early adulthood, at an average age of around 25 years, though it can start anywhere between ages 15 and 37. During this transition, some childhood features like seizures often become less prominent or resolve entirely, while new and progressive symptoms take their place.
The defining features of this second phase are parkinsonism and dystonia. Dystonia, which causes muscles to contract involuntarily and hold abnormal postures, tends to start in the arms and hands. Parkinsonism brings slowness of movement, muscle rigidity, freezing of gait (where the feet seem stuck to the floor mid-step), and problems with balance. Unlike typical Parkinson’s disease, tremor is not a prominent feature in BPAN. Together, these movement problems become increasingly disabling over time, with progressive difficulty walking being one of the most significant challenges.
Cognitive decline also emerges during this phase, sometimes described as dementia. It typically becomes noticeable during the mid-to-late twenties and compounds the intellectual disability already present from childhood. The combination of worsening movement control and declining cognition means that individuals gradually need more support with daily activities.
How BPAN Is Diagnosed
Diagnosis relies on a combination of genetic testing and brain imaging. An MRI can reveal iron deposits in the globus pallidus and substantia nigra, two structures deep in the brain. BPAN produces a distinctive MRI signature that helps set it apart from other iron-accumulation disorders: on certain image types (T1-weighted scans), the substantia nigra appears bright with a dark central band running through it. This specific pattern has not been found in other NBIA disorders and can point clinicians toward BPAN before genetic results come back.
Genetic testing that identifies a mutation in the WDR45 gene confirms the diagnosis. Because many childhood features overlap with other conditions, including Rett syndrome and various epileptic syndromes, some individuals are diagnosed only after the movement disorder phase begins or after broader genetic panels are ordered.
Management and Daily Life
There is currently no treatment that reverses or halts the underlying disease process in BPAN. Care focuses on managing symptoms as they arise. In childhood, this means addressing seizures (which can be complex and require tailored approaches), sleep disturbances, and behavioral challenges. Therapies for speech, movement, and daily living skills play a central role throughout life.
As parkinsonism and dystonia develop, management shifts toward controlling movement symptoms and maintaining as much independence and comfort as possible. The supportive care approach evolves with each individual’s changing needs, and a team that includes neurologists, therapists, and other specialists typically coordinates care over the long term.
Life Expectancy and Outlook
A systematic review of 160 published cases found that overall survival was high through early adulthood: 96.9 percent of individuals were alive at their last reported follow-up. Mortality remained low through age 39, with an estimated survival probability for females of 97.6 percent at age 27 and 91.9 percent at age 39. All reported deaths occurred in females; every male in the study was alive at last follow-up, with the oldest reported male being 44 years old. Reliable survival estimates beyond age 39 aren’t yet available simply because so few older cases have been documented in the medical literature.
The clinical picture varies widely from person to person. While the two-phase pattern of childhood developmental issues followed by adult-onset movement disorder and cognitive decline is consistent, the severity and timing of each feature can differ significantly. Because BPAN was only recently characterized as a distinct condition (identified in 2012), the understanding of its long-term trajectory continues to grow as more individuals are followed over time.